BioVie Inc. - Common stock (BIVI)
1.6700
-0.0000 (-0.00%)
Biovie Inc is a biotechnology company focused on developing innovative therapeutic solutions for neurological and psychiatric disorders
The company is dedicated to advancing its proprietary drug candidates through rigorous clinical research, aiming to address unmet medical needs in these fields. By leveraging cutting-edge science and technology, Biovie Inc seeks to improve treatment options and outcomes for patients suffering from various conditions, demonstrating a commitment to enhancing quality of life through effective healthcare solutions.
Previous Close | 1.670 |
---|---|
Open | 1.690 |
Bid | 1.670 |
Ask | 1.690 |
Day's Range | 1.661 - 1.690 |
52 Week Range | 1.040 - 33.10 |
Volume | 24,499 |
Market Cap | 29.67M |
PE Ratio (TTM) | -0.2163 |
EPS (TTM) | -7.7 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 954,145 |
News & Press Releases
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 28, 2025
BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / New to The Street, a leading FMW Media production, is thrilled to announce its partnership with BioVie Inc. (NASDAQBIVI), a clinical-stage biopharmaceutical company developing innovative therapies for neurodegenerative disorders and advanced liver disease. This partnership will launch a dynamic six-part media campaign designed to amplify BioVie's groundbreaking work to audiences across multiple platforms.
Via ACCESSWIRE · January 13, 2025
BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioVie Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BioVie Inc. (NASDAQBIVI) on behalf of long-term stockholders following a class action complaint that was filed against BioVie on January 19, 2024 with a Class Period from August 5, 2021 to November 29, 2023. Our investigation concerns whether the board of directors of BioVie have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · January 2, 2025
Why BioVie (BIVI) Stock Is Down Over 50% Todaybenzinga.com
BioVie shares are trading lower by 53% during Tuesday's session. The company announced it raised $3 million through a secondary offering.
Via Benzinga · September 24, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 24, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 23, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · October 23, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 23, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 22, 2024
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 22, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · October 21, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 21, 2024
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 21, 2024
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / October 11, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · October 11, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · September 26, 2024
Nasdaq Surges 100 Points; Thor Industries Earnings Top Viewsbenzinga.com
Via Benzinga · September 24, 2024
Dow Rises Over 50 Points; AutoZone Posts Downbeat Earningsbenzinga.com
Via Benzinga · September 24, 2024
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 24, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Mondayinvestorplace.com
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
Via InvestorPlace · August 12, 2024
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / July 5, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 6, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · July 5, 2024
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / June 21, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Mobilicom Ltd. (Nasdaq:MOB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 22, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Via ACCESSWIRE · June 21, 2024